UTERINE LEIOMYOMA: CLINICAL MANIFESTATIONS AND PERCEIVED IMPACT ON WOMEN’S HEALTH LIFE

Authors

  • AISWARYA THAMPI Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India. https://orcid.org/0000-0001-6966-4487
  • AMRITHA LAKSHMAN Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India. https://orcid.org/0000-0002-8592-950X
  • SHEBA MARY CHERIYAN Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India.
  • SHIBILA SHARAF Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India. https://orcid.org/0000-0003-2389-4361
  • RAJEEV P THOMAS Department of Pharmacy Practice, National College of Pharmacy, Kozhikode, Kerala, India.
  • HEERA SHENOY T Department of Obstetrics and gynaecology, KMCT Medical College, Kozhikode, Kerala, India. https://orcid.org/0000-0001-6197-0236

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i4.46515

Keywords:

UL, Fibroids, Quality of life, Clinical manifestations, Perceived impact, Stress

Abstract

Objectives: Uterine leiomyoma/uterine fibroid is the benign tumor of the smooth muscle of the uterus. This study was conducted to identify the clinical features and the effects on their quality of life factors with the occurrence of uterine fibroids.

Methods: A cross-sectional study research design was used. The sample constituted 370 patients diagnosed with uterine fibroids, starting from November 2021 to May 2022.

Results: Heavy menstrual bleeding was found to be the most common clinical manifestation seen in women with uterine leiomyoma. Hypothyroidism was seen to be associated with uterine leiomyoma. Generalized fatigue was the main issue faced by many along with difficulty to do daily chores. All these issues caused mental stress in women to a large extent.

Conclusion: The associated factors, clinical manifestations, and perceived impact on women’s health life of uterine leiomyoma were studied. Age (41–60), overweight, and family history were the associated factors of uterine leiomyoma. Uterine fibroids negatively impacted the quality of life in women.

Downloads

Download data is not yet available.

References

Millien C, Manzi A, Katz AM, Gilbert H, Fawzi MC, Farmer PE, et al. Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: Implications for advancing a health equity agenda, a mixed methods study. Int J Equity Health 2021;20:1-7.

Subramaniyam NK, Kandluri V, Chadeve A, Modapu D, Dumpala AJ, Gudise BR, et al. Prevalence of risk factors for uterine fibroids at tertiary care teaching hospital: A cross-sectional study. J Young Pharm 2020;12:86-9.

Fonseca-Moutinho JA, Barbosa LS, Torres DG, Nunes SM. Abnormal uterine bleeding as a presenting symptom is related to multiple uterine leiomyoma: An ultrasound-based study. Int J Womens Health 2013;5:689-94.

Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: An international internet-based survey of 21,746 women. BMC Womens Health 2012;12:6.

Fuldeore MJ, Soliman AM. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: Findings from a cross-sectional survey analysis. Int J Womens Health 2017;9:403-11.

Stewart EA, Nicholson WK, Bradley L, Borah BJ. The burden of uterine fibroids for African-American women: Results of a national survey. J Womens Health (Larchmt) 2013;22:807-16.

Yao X, Stewart EA, Laughlin-Tommaso SK, Heien HC, Borah BJ. Medical therapies for heavy menstrual bleeding in women with uterine fibroids: A retrospective analysis of a large commercially insured population in the USA. BJOG 2017;124:322-30.

Vines AI, Ta M, Esserman DA. The association between self-reported major life events and the presence of uterine fibroids. Womens Health Issues 2010;20:294-8.

Krishnan P, Ganapathy D, Marimuthu BP. Awareness about fibroid among Indian women. Drug Invent Today 2020;13:113-8.

Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2018;46:3-11.

Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: An ultrasound-screening study. Obstet Gynecol 2009;113:630-5.

Khan AT, Shehmar M, Gupta JK. Uterine fibroids: Current perspectives. Int J Womens Health 2014;6:95-114.

Bachmann GA, Bahouth LA, Amalraj P, Mhamunkar V, Hoes K, Ananth CV. Uterine fibroids: Correlations of anemia and pain to fibroid location and uterine weight. J Reprod Med 2011;56:463-6.

Donnez J, Dolmans MM. Uterine fibroid management: From the present to the future. Hum Reprod Update 2016;22:665-86.

Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd SL, Maroulis C, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 2010;152:96-102.

Published

07-04-2023

How to Cite

THAMPI, A., A. LAKSHMAN, S. M. CHERIYAN, S. SHARAF, R. P. THOMAS, and H. SHENOY T. “UTERINE LEIOMYOMA: CLINICAL MANIFESTATIONS AND PERCEIVED IMPACT ON WOMEN’S HEALTH LIFE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 4, Apr. 2023, pp. 21-24, doi:10.22159/ajpcr.2023.v16i4.46515.

Issue

Section

Original Article(s)